Drug
Trifluridine Tipiracil Chemoradiation
Trifluridine Tipiracil Chemoradiation: highest development phase Phase 1/2, developed by Endo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Endo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trifluridine/tipiracil chemoradiation NCT04177602 | Phase 1/2 | Locally Advanced Rectal Cancer |
Latest
No recent events.
Follow Trifluridine Tipiracil Chemoradiation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.